1. Home
  2. CISO vs UBX Comparison

CISO vs UBX Comparison

Compare CISO & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CISO
  • UBX
  • Stock Information
  • Founded
  • CISO 2015
  • UBX 2009
  • Country
  • CISO United States
  • UBX United States
  • Employees
  • CISO N/A
  • UBX N/A
  • Industry
  • CISO Computer Software: Prepackaged Software
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CISO Technology
  • UBX Health Care
  • Exchange
  • CISO Nasdaq
  • UBX Nasdaq
  • Market Cap
  • CISO 32.7M
  • UBX 38.6M
  • IPO Year
  • CISO N/A
  • UBX 2018
  • Fundamental
  • Price
  • CISO $1.26
  • UBX $2.19
  • Analyst Decision
  • CISO
  • UBX Strong Buy
  • Analyst Count
  • CISO 0
  • UBX 2
  • Target Price
  • CISO N/A
  • UBX $7.00
  • AVG Volume (30 Days)
  • CISO 112.2K
  • UBX 330.7K
  • Earning Date
  • CISO 11-18-2024
  • UBX 11-04-2024
  • Dividend Yield
  • CISO N/A
  • UBX N/A
  • EPS Growth
  • CISO N/A
  • UBX N/A
  • EPS
  • CISO N/A
  • UBX N/A
  • Revenue
  • CISO $54,633,909.00
  • UBX N/A
  • Revenue This Year
  • CISO $78.76
  • UBX N/A
  • Revenue Next Year
  • CISO N/A
  • UBX $33.62
  • P/E Ratio
  • CISO N/A
  • UBX N/A
  • Revenue Growth
  • CISO 34.87
  • UBX N/A
  • 52 Week Low
  • CISO $0.26
  • UBX $0.94
  • 52 Week High
  • CISO $3.84
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • CISO 54.18
  • UBX 58.41
  • Support Level
  • CISO $0.96
  • UBX $1.81
  • Resistance Level
  • CISO $1.03
  • UBX $2.39
  • Average True Range (ATR)
  • CISO 0.09
  • UBX 0.24
  • MACD
  • CISO 0.05
  • UBX -0.05
  • Stochastic Oscillator
  • CISO 80.22
  • UBX 59.38

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: